SE467987B - Saett att bestaemma maengden av ett tumoerantigen-immunokomplex - Google Patents

Saett att bestaemma maengden av ett tumoerantigen-immunokomplex

Info

Publication number
SE467987B
SE467987B SE8401424A SE8401424A SE467987B SE 467987 B SE467987 B SE 467987B SE 8401424 A SE8401424 A SE 8401424A SE 8401424 A SE8401424 A SE 8401424A SE 467987 B SE467987 B SE 467987B
Authority
SE
Sweden
Prior art keywords
insolubilized
antibody
labeled
substance
complement
Prior art date
Application number
SE8401424A
Other languages
English (en)
Swedish (sv)
Other versions
SE8401424D0 (sv
SE8401424L (sv
Inventor
M Ishii
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE8401424D0 publication Critical patent/SE8401424D0/xx
Publication of SE8401424L publication Critical patent/SE8401424L/
Publication of SE467987B publication Critical patent/SE467987B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57476—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8401424A 1982-07-16 1984-03-14 Saett att bestaemma maengden av ett tumoerantigen-immunokomplex SE467987B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12494582A JPS5915858A (ja) 1982-07-16 1982-07-16 腫瘍関連抗原特異的免疫複合体の測定法
PCT/JP1983/000228 WO1984000421A1 (en) 1982-07-16 1983-07-14 Method for assaying tumor-associated antigen-specific immune complex

Publications (3)

Publication Number Publication Date
SE8401424D0 SE8401424D0 (sv) 1984-03-14
SE8401424L SE8401424L (sv) 1984-03-14
SE467987B true SE467987B (sv) 1992-10-12

Family

ID=14898080

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401424A SE467987B (sv) 1982-07-16 1984-03-14 Saett att bestaemma maengden av ett tumoerantigen-immunokomplex

Country Status (7)

Country Link
EP (1) EP0100914B1 (de)
JP (1) JPS5915858A (de)
CH (1) CH662427A5 (de)
DE (1) DE3367281D1 (de)
GB (1) GB2133146B (de)
SE (1) SE467987B (de)
WO (1) WO1984000421A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77700T1 (de) * 1986-03-10 1992-07-15 Imre Corp Immunkomplextestverfahren.
US5179000A (en) * 1987-07-24 1993-01-12 Nippon Kayaku Kabushiki Kaisha Method for assaying basic fetoprotein in urine and assay kit therefor
US5840317A (en) * 1989-11-03 1998-11-24 Morton; Donald L. Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen
US5882654A (en) * 1989-11-03 1999-03-16 Morton; Donald L. Polyvalent melanoma vaccine
EP0498851B1 (de) * 1989-11-03 1996-01-03 MORTON, Donald L. Harnwegstumor-assoziiertes antigen, verwendung von antigenen untereinheiten und nachweisverfahren
RO114835B1 (ro) * 1997-03-17 1999-07-30 Ioan Puşcaş Metodă rapidă de diagnostic al cancerelor
ITPD20030264A1 (it) * 2003-10-30 2005-04-30 Xeptagen Spa Metodo di diagnosi altamente specifico per neoplasie

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1590524A (en) * 1976-11-24 1981-06-03 Nat Res Dev Assay of immune complexes
ES471585A1 (es) * 1977-07-15 1979-01-16 Behringwerke Ag Procedimiento para la determinacion de reactivos fc
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
CA1166957A (en) * 1980-05-08 1984-05-08 Barry I. Bluestein Immunoassay for oncofetal antigen carried by lymphocytes
EP0057236A4 (de) * 1980-07-25 1982-10-14 Otsuka Pharma Co Ltd Verfahren zum feststellen der tumorgebundenen glukoseseitenkette, verfahren zur diagnose von tumoren sowie "kit" dazu.
JPS5729950A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination method of sugar side chain related to cancer
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
JPS5729951A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determintion of sugar side chain related to cancer
EP0070278B1 (de) * 1980-10-24 1986-04-30 PARRATT, David Diagnostisches verfahren

Also Published As

Publication number Publication date
GB8403775D0 (en) 1984-03-21
GB2133146B (en) 1986-01-08
DE3367281D1 (en) 1986-12-04
EP0100914A1 (de) 1984-02-22
WO1984000421A1 (en) 1984-02-02
CH662427A5 (de) 1987-09-30
SE8401424D0 (sv) 1984-03-14
EP0100914B1 (de) 1986-10-29
JPS5915858A (ja) 1984-01-26
SE8401424L (sv) 1984-03-14
GB2133146A (en) 1984-07-18

Similar Documents

Publication Publication Date Title
CA1225586A (en) Method of performing an immuno-assay, article for use therein and method for making such article
Menendez-Botet et al. A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.
US4514508A (en) Assaying for a multiplicity of antigens or antibodies with a detection compound
US4389392A (en) Determination of tumor associated glycolinkage and diagnosis of cancers
US4343896A (en) Method and test pack for the demonstration and determination of an antigen or antibody
US5187065A (en) Method and materials for detecting lyme disease
AU777117B2 (en) Immunoassay for measuring human C-peptide and kit therefor
US4526871A (en) Conjugate obtained by coupling a lectin and a specific ligand, containing such a conjugate and its applications in biology
US4420461A (en) Agglutination-inhibition test kit for detecting immune complexes
EP0166623A2 (de) Antikörper-Lectin-Sandwichtest
EP0064274B1 (de) Verfahren zur Bestimmung von Antigen-Antikörper-Reaktionen und Reagens hierfür
US4299815A (en) Carcinoembryonic antigen determination
CA1340973C (en) Immunometric assay kit and method applicable to whole cells
SE467987B (sv) Saett att bestaemma maengden av ett tumoerantigen-immunokomplex
US6461825B1 (en) Immunometric assay kit and method applicable to whole cells
US5919632A (en) Use of polyclonal human anti-HTG autoantibodies as a reagent for the clinical diagnosis of thyroid autoimmune diseases and reagent additive for detecting anti-HTG autoantibodies in patient sera
CA1231047A (en) Diagnostic test for rheumatological diseases
EP0662611B1 (de) Verfahren zur Bestimmung vom rheumatoiden Faktor und Kit dazu
US4427779A (en) Agglutination-inhibition test method for detecting immune complexes
EP0683396A1 (de) Verfahren zur bestimmung spezifischer antikörper
WO1999010745A1 (en) Methods and devices for detecting non-complexed prostate specific antigen
EP0549974B1 (de) Immunoassay für NCA-BT in Blutproben von Brustkrebspatientinnen
WO2008068554A1 (en) Complement-based analyte assay
US5707878A (en) Method for detecting blood component using conidiobolus hemagglutinin
US4525459A (en) New purified glycoproteins and use in diagnosing infectious mononucleosis

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401424-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8401424-0

Format of ref document f/p: F